Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outset Medical (OM) Operating Leases (2020 - 2025)

Historic Operating Leases for Outset Medical (OM) over the last 6 years, with Q4 2025 value amounting to $5.0 million.

  • Outset Medical's Operating Leases rose 8666.17% to $5.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $5.0 million, marking a year-over-year increase of 8666.17%. This contributed to the annual value of $5.0 million for FY2025, which is 8666.17% up from last year.
  • Outset Medical's Operating Leases amounted to $5.0 million in Q4 2025, which was up 8666.17% from $1.2 million recorded in Q3 2025.
  • Outset Medical's 5-year Operating Leases high stood at $7.8 million for Q1 2021, and its period low was $1.2 million during Q3 2025.
  • Over the past 5 years, Outset Medical's median Operating Leases value was $5.1 million (recorded in 2023), while the average stood at $4.9 million.
  • Data for Outset Medical's Operating Leases shows a peak YoY increase of 8666.17% (in 2025) and a maximum YoY decrease of 6059.55% (in 2025) over the last 5 years.
  • Over the past 5 years, Outset Medical's Operating Leases (Quarter) stood at $6.9 million in 2021, then dropped by 19.11% to $5.6 million in 2022, then decreased by 19.62% to $4.5 million in 2023, then plummeted by 40.12% to $2.7 million in 2024, then soared by 86.66% to $5.0 million in 2025.
  • Its Operating Leases stands at $5.0 million for Q4 2025, versus $1.2 million for Q3 2025 and $1.7 million for Q2 2025.